[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Arteris, Inc. insider notice reports a proposed sale under Rule 144 of 11,841 common shares with an aggregate market value of $130,014.18. The shares were acquired on 01/28/2021 through previously exercised stock options and were paid for in cash. The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker and lists an approximate sale date of 10/06/2025 on NASDAQ. The notice also discloses a prior sale on 08/05/2025 of 6,909 shares generating $97,699.48, and includes the standard Rule 10b5-1 representation and signature attestation.

Positive

• 11,841 shares identified for sale were acquired on 01/28/2021 via previously exercised stock options
• Proposed sale lists a named institutional broker: Morgan Stanley Smith Barney LLC
• Filer included prior sale detail: 6,909 shares sold on 08/05/2025 for $97,699.48, showing transaction transparency

Negative

• Proposed insider sale of 11,841 shares with market value $130,014.18 may be viewed unfavorably by some investors
• Recent sale activity ( 6,909 shares on 08/05/2025 ) indicates ongoing insider liquidity events

Insights

Corporate Insider

Small scheduled insider sale from exercised options; shows planned liquidity, not new issuance.

The filing documents a proposed Rule 144 sale of 11,841 common shares acquired via previously exercised stock options on 01/28/2021, indicating the shares are not newly issued but derived from an earlier compensation event. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services and the sale is tentatively dated 10/06/2025.

Key dependencies include timing of execution and whether the seller relies on a 10b5-1 plan; the form contains the usual attestation about material nonpublic information. Watch for an actual Form 4 or trade report shortly after 10/06/2025 to confirm execution and proceeds.

Securities Compliance Analyst

Filing follows Rule 144 mechanics and includes prior 10b5-1 sales disclosure.

The notice lists acquisition details, purchase consideration (cash), and prior sales including a 08/05/2025 trade of 6,909 shares for $97,699.48, meeting disclosure expectations under Rule 144. The seller makes the required representation about material nonpublic information.

Compliance attention should focus on any accompanying 10b5-1 plan dates and subsequent public filings showing actual sales; those items will clarify whether the transactions were preplanned or discretionary within the near term.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11841	130014.18	42649917	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/28/2021	Previously Exercised Stock Options	Issuer			11841	01/28/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for VIANA FAMILY TRUST U/A DTD 07/12/2007 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	6909	97699.48

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Arteris (AIP) disclose in this Form 144?

The filing reports a proposed Rule 144 sale of 11,841 common shares valued at $130,014.18, to be sold approximately on 10/06/2025, acquired via exercised options on 01/28/2021.

Who is the broker handling the proposed sale for AIP?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

Were any shares of Arteris sold recently by the same account?

Yes. The filing shows a prior sale on 08/05/2025 of 6,909 shares, generating $97,699.48 in gross proceeds.

How were the shares acquired that are now proposed for sale?

The shares were acquired on 01/28/2021 through previously exercised stock options, and payment was made in cash.

Does the filing state whether a 10b5-1 trading plan is in effect?

The form includes the standard 10b5-1 attestation area, but no specific plan adoption date is provided in the visible content.